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Abstract Cytochrome c oxidase is a multiprotein complex in
the mitochondrial membrane whose biogenesis requires a number
of proteins besides the structural subunits. Several yeast proteins
as well as a human disease-related protein have been reported
which are involved in cytochrome c oxidase assembly. The S.
cerevisiae Sco1p protein has been implicated in the transfer of
copper to cytochrome c oxidase subunits Cox1p and/or Cox2p.
Here we report on the complementation behavior in yeast of two
recently identified ScSco1p homologs of chromosome 17 and
chromosome 22 from human. When allotropically expressed in
yeast, both genes fail to complement the lack of the ScSCO1
gene. However, a chimera of the N-terminal half of ScSco1p and
the C-terminal half of the chromosome 17 homolog does
substitute for the ScSco1p function. Interestingly, the respective
chimera with the human homolog of chromosome 22 is not able
to complement. Expression of EGFP fusions in HeLa cells shows
that both human ScSco1p homologs are located in the
mitochondria of human cells.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Cytochrome c oxidase (COX) is an essential constituent of
the mitochondrial respiratory chain. In yeast, mutations af-
fecting COX lead to respiratory de¢ciency. In human, genetic
de¢ciencies of COX are often associated with human pathol-
ogies [1]. Recently a human gene (SURF1) has been identi¢ed
which, if mutated, causes Leigh syndrome [2]. The SURF1
gene product, which is not a COX subunit, is the ¢rst example
of a human protein involved in the COX assembly.
In yeast, a number of proteins involved in the COX bio-
genesis have been identi¢ed [3]. One of these proteins is
Sco1p. This nuclear encoded protein is anchored in the inner
mitochondrial membrane by a single transmembrane segment
[4]. The major carboxy-terminal part of ScSco1p protrudes
into the mitochondrial intermembrane space (IMS) [5,6].
Strains lacking SCO1 are respiratory de¢cient because newly
synthesized Cox1p and Cox2p are rapidly degraded [7,8].
Based on the ¢ndings that overexpression of Sco1p, even bet-
ter in combination with slightly elevated concentrations of
copper in the growth medium, can partially suppress the de-
¢ciency of Cox17p, a copper-binding protein in the cytosol
and the IMS, it was suggested that ScSco1p might be involved
in the attachment of copper to COX [6,9]. In support of this
view is the presence of a potential metal-binding motif CxxxC,
which is essential for the ScSco1p function [10]. Two cysteine
residues separated by three amino acids have been shown to
contribute to a copper-binding site in Cox2p [11], but are also
characteristic for ferredoxins [12].
Many aspects of copper homeostasis seem to be evolution-
ary conserved from yeast to human [13]. During the last years,
human homologs to ScAtx1p (Hah1p, [14]), ScCcc2p (Wilson
disease protein, [15]), ScCtr1p (hsCtr1p, [16]) and ScCox17p
(hsCox17p, [17]) have been identi¢ed. In all cases, the human
homologs were able to substitute for the authentic protein in
yeast.
In the course of the systematic sequencing projects, a num-
ber of DNA sequences with a high degree of homology to the
S. cerevisiae ScSCO1 gene were detected. Among these are
homologs on chromosome 2 of S. cerevisae (ScSCO2) [18]
and on chromosome 22 (HsSCO1 (chr. 22)) as well as of
chromosome 17 (HsSCO1 (chr. 17)) [19] in human. We here
report that the two human homologs by themselves fail to
functionally complement the respiratory de¢ciency of a sco1
null mutant. A chimeric protein with the C-terminal half de-
rived from HsSco1p (chr. 17) and the N-terminal half from
ScSco1p, however, can substitute for ScSco1p, while a similar
construct with HsSco1p (chr. 22) is not functional in yeast.
Mitochondrial localization of the human homologs in HeLa
cells is demonstrated by use of fusions of the HsSco1 reading
frames to EGFP.
2. Materials and methods
2.1. Strains and media
Escherichia coli strain DH5K (BRL) was used in this work. Saccha-
romyces cerevisiae strain GR20 (MATK, leu2-3, leu2-112, his3-11, his3-
15, ura3-228, ura3-251, ura3-372, sco1: :URA3) [20] was employed for
the complementation analysis. Media were as described [21].
2.2. Plasmids
The oligonucleotide primers used for PCRs are listed in Table 1.
The construct YEp351/ScSco1 contains the promoter, the encoding
region and the terminator of ScSCO1 [10]. A cDNA clone containing
the HsSCO1 gene (chr. 22) was obtained from Luc Smink (Sanger
Centre, Hinxton, UK) and a cDNA clone containing the HsSCO1
gene (chr. 17) was provided by Prof. Massimo Zeviani (National
Neurological Institute ‘C. Besta’, Milano, Italy). Construct p415
ADH-HsSco1 (chr. 22) was obtained by cloning a PCR product
(primers 1 and 2) into the BamHI-SalI sites of the vector p415
ADH [22]. A similar strategy was used for construct p415 ADH-
HsSco1 (chr. 17) (primers 3 and 4). ScSco1p(1^158) and ScSco1p-
(1^258) were obtained by PCR using primers 5, 6 and 5, 7, respec-
tively, and YEp351/ScSco1 as template. The PCR products were
cloned in the SacI, SalI sites of plasmid YEp351 [23].
Chimeras under the control of the ScSCO1 promoter were obtained
by sequential PCR and cloned into the vector YEp351. For
ScSco1p(1^95)/HsSco1p (chr. 22)(83^266), the initial two PCRs (a
and b) were performed with primers 5, 9 (ScSCO1 from the position
3317 to +285) and 8, 2 (HsSCO1 from the position +247 to +801),
respectively. The complementary sequences of the primers 8 and 9 are
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underlined (see Table 1). The switch between ScSCO1 and HsSCO1 is
indicated (/). The two PCR products, which have a common 18 bp
overlap were used as templates in a third PCR (c) with primers 5 and
2 to create the chimeric gene. After cleavage with SacI and SalI, the
fragment was cloned into YEp351 which was cut with the same re-
striction enzymes.
The same strategy was used to construct the other chimeras with
the primers listed in Table 2.
The fusion construct between the HsSco1p (chr. 22) and the EGFP
protein was obtained by cloning a PCR product (primers 25, 26) into
the HindIII-SacII sites of the pEGFP-N1 vector (Clontech). A similar
strategy was used for the fusion construct between HsSco1p (chr. 17)
and EGFP (primers 27, 28).
The nucleotide sequence of all constructs was con¢rmed by se-
quencing.
2.3. Cell culture and transfection
HeLa cells were grown in Dulbecco’s modi¢ed Eagle medium
(DMEM) containing 10% fetal calf serum (complete medium). Cul-
tures were maintained at 37‡C in a humidi¢ed atmosphere containing
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Table 1
Primers for PCR
Primer Sequence (5PC3P) Position
1 TATAGGATCCATATGCTGCTGCTGACTCGGAGCCC HsSCO1 (chr. 22) +1
2 TATAGGATCCGTCGACTCAAGACAGGACACTGCGG HsSCO1 (chr. 22) +801
3 TATATAGGATCCATGGCGATGCTGGTCCTAGTACCC HsSCO1 (chr. 17) +1
4 TATATATAGTCGACCTAGCTCTTTTTTCTGTATGGCCT HsSCO1 (chr. 17) +906
5 GTCCTCGAGCTCCCAATTGAAACTAAATTG ScSCO1 3317
6 TATATATAGTCGACTTATTACTTATCCAGTTCATCAGGACAGAT ScSCO1 +474
7 ATATATAAGCTTCTATCATCTACCCAAAGCATCAACA ScSCO1 +774
8 AGGGAGAAA/GAGAGGCTGCAGCAGCAAAAG HsSCO1 (chr. 22) +247
9 CAGCCTCTC/TTTCTCCCTGTTGAAGAAATA ScSCO1 +285
10 CTGGATAAG/CTGGTGCAGGTGGTGCGGCAG HsSCO1 (chr. 22) +430
11 CTGCACCAG/CTTATCCAGTTCATCAGGACA ScSCO1 +474
12 CAGCCATTA/TTCATCACTGTGGACCCCGAGCGG HsSCO1 (chr. 22) +490
13 AGTGATGAA/TAATGGCTGCAGAGTAATACCATA ScSCO1 +531
14 CCAGCAAGA/GACGACGTTGAAGCCATGGCCCGC HsSCO1 (chr. 22) +514
15 AACGTCGTC/TCTTGCTGGATCACAAGTTATAAA ScSCO1 +555
16 AGAGTATAC/TACAATGCCGGCCCCAAGGATGAG HsSCO1 (chr. 22) +625
17 GGCATTGTA/GTATACTCTGTACTTCTTGCATGC ScSCO1 +666
18 CGTAGAAAA/GTACACGCGGTAACTGTGACTAGC HsSCO1 +624
19 CGCGTGTAC/TTTTCTACGCCTCCAAACGTCAAA ScSCO1 +667
20 TATATATGTCGACCTTCCCACGTTCACATAG ScSCO1 +1043
21 AGGGAGAAG/AAGGAAAAGGCAGAGAAGTTAGAGAAG HsSCO1 (chr. 17) +349
22 CTTTTCCTT/CTTCTCCCTGTTGAAGAAATAAGAAAG ScSCO1 +285
23 CTGGACAAG/ATGATCCAAGTCGTGGATGAAATAGATAGC HsSCO1 (chr. 17) +538
24 TTGGATCAT/CTTGTCCAGTTCATCAGGACAGAT ScSCO1 +474
25 AGTATAAAGCTTATGCTGCTGCTGACTCGGAGCCCC HsSCO1 (chr. 22) +1
26 AGTATACCGCGGAGACAGGACACTGCGGAAAGCCGC HsSCO1 (chr. 22) +798
27 TATATAAAGCTTATGGCGATGCTGGTCCTAGTACCC HsSCO1 (chr. 17) +1
28 TATATATACCGCGGGCTCTTTTTTCTGTATGGCCTCAT HsSCO1 (chr. 17) +903
Note: primer annealing regions are shown in bold letters. Numbers on the right indicate the 5P positions of the annealing regions in the respective
genes. Overlapping sequences are underlined, (/) indicates the switch between two genes.
Fig. 1. Multiple alignment of homologs of ScSco1p. Identical amino acids are shown in bold letters. Identities to ScSco1p are: Saccharomyces
cerevisiae Sco2p (ScSco2p) 51.01%; Homo sapiens Sco1p on chromosome 22 (HsSco1p (chr. 22)) 30.36% and on chromosome 17 (HsSco1p
(chr. 17)) 23.06%. Potential TM regions are underlined.
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5% CO2. For transient expression, cells were subcultured in TC
Chamber Slides (Nunc Lab-Tek) and transformed using liposome-
mediated transfection (Tfx-20, Promega) as described by the manu-
facturer. Transfectants were visualized with a £uorescence microscope
(JenaLumar) 24 h after transfection. For staining of mitochondria,
cells were incubated for 30 min in the presence of 50 nM Mito Track-
er Red CMXros (Molecular Probes).
2.4. Miscellaneous procedures
Standard techniques were used for restriction endonuclease analysis
of DNA, puri¢cation and ligation of DNA fragments, transforma-
tions and the recovery of plasmid DNA from E. coli [24]. Yeast trans-
formations employed a LiAc procedure [25]. DNA sequences were
determined by the dideoxy chain termination method of Sanger [26]
using 5P IRD800-labelled primers (MWG-BIOTECH) and the Ther-
mo Sequenase £uorescent labelled primer cycle sequencing kit with 7-
deaza-dGTP (Amersham Pharmacia Biotech) and the LI-COR DNA
sequencer, model 4000 (MWG-BIOTECH).
3. Results and discussion
The homologs of ScSco1p share a high degree of similarity
with respect to the primary sequence (see Fig. 1) and to their
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Fig. 2. Overview of Sco1p constructs tested. A: Schematic presentation of ScSco1p and ScSco1p C-terminally truncated versions. B: Schematic
presentation of HsSco1p (chr. 17) and ScSco1p/HsSco1p (chr. 17) chimeras. C: Schematic presentation of HsSco1p (chr. 22) and ScSco1p/
HsSco1p (chr. 22) chimeras. P indicates the putative mitochondrial pre-sequence, TM the putative transmembrane domain and CxxxC the po-
tential metal-binding site. The thin arrow indicates the ScSCO1 promoter and the fat arrow the ADH1 promoter. Sequences derived from
ScSco1p are in white, from HsSco1p (chr. 17) in dark grey and from HsSco1p (chr. 22) in light grey. Growth of GR20 transformants on
YPGly are indicated on the right side: + = growth, 3= no growth.
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overall structure. All contain a hydrophobic stretch in the
amino-terminal third with the potential to act as a transmem-
brane (TM) region. Their N-termini are reminiscent of mito-
chondrial pre-sequences in that they lack negatively charged
amino acids while they contain positively charged and hy-
droxylated amino acid residues [27]. The putative metal-bind-
ing motif CxxxC is conserved from yeast to human. Although
the high degree of homology suggests that the proteins might
be functional homologs of ScSco1p, it was reported that the
ScSCO2 gene is not a functional homolog of ScSCO1, neither
does it restore the respiratory competence in a Scsco1 null
mutant nor does deletion of ScSCO2 result in a respiratory
de¢cient phenotype [9].
In order to determine whether the homologous human
genes of chromosome 17 (sequence ID: AF026852) and chro-
mosome 22 (sequence ID: AL021683) are functional homo-
logs on ScSCO1, we tested them for their ability to substitute
for ScSCO1.
The respective cDNAs of the homologs were cloned behind
the strong S. cerevisiae ADH1 promoter (see Section 2) and
transformed into strain GR20, which is deleted for ScSCO1.
Both constructs fail to restore respiratory competence (see
Figs. 2 and 3), i.e. the genes are not per se functional homo-
logs of ScSCO1. The N-terminal part of ScSco1p contains a
mitochondrial import sequence and the predicted TM region
which direct the protein to mitochondria and anchor it in the
inner mitochondrial membrane [4]. To exclude the possibility
that the import signal and/or the TM region of the human
proteins are not functional in S. cerevisiae, we constructed
chimeras consisting of the N-terminal 95 amino acids of
ScSco1p (including the import signal and TM region) and
the C-terminus of the human homologs of chromosome 17
(ScSco1p(1^95)/HsSco1p (chr. 17)(117^301)) and chromosome
22 (ScSco1p(1^95)/HsSco1p (chr. 22)(83^266)), respectively.
These constructs, too, proved not to be able to complement
the respiratory de¢ciency of strain GR20 (see Fig. 2).
In a second set of chimeras, the N-terminal 158 amino acids
of ScSco1p up to the CxxxC motif were fused to the C-termini
of the respective human homologs of chromosome 22
(ScSco1p (1^158)/HsSco1p (chr. 22)(144^266)) and chromo-
some 17 (ScSco1p (1^158)/HsSco1p (chr. 17)(180^301)). In a
control experiment, we showed that the amino-terminal 158
amino acids of ScSco1p (ScSco1p(1^158)) alone do not restore
the respiratory competence in the vsco1 strain GR20. Inter-
estingly, the ScSco1p(1^158)/HsSco1p (chr. 17)(180^301) chi-
mera restored the respiratory competence in GR20, while the
chimeric protein ScSco1p(1^158)/HsSco1p (chr. 22)(144^266)
did not (see Figs. 2 and 3). Transformants bearing ScSco1p-
(1^158)/HsSco1p (chr. 17)(180^301) show a slight cold sensi-
tive phenotype, i.e. a somewhat reduced growth rate at 23‡C
as compared to 30‡C or 37‡C (data not shown). The di¡erence
in complementation behavior is not due to a proteolytic
sensitivity of ScSco1p(1^158)/HsSco1p (chr. 22)(144^266),
as a protein of the expected molecular mass can be detected
with ScSco1p antibodies in Western analysis (data not
shown).
FEBS 21734 18-3-99 Cyaan Magenta Geel Zwart
Table 2
Primers used in the construction of the chimeras
Construct PCR a PCR b PCR c
ScSco1p(1^95)/HsSco1p (chr. 22)(83^266) 5, 9a 8, 2b 5, 2
ScSco1p(1^158)/HsSco1p (chr. 22)(144^266) 5, 11a 10, 2b 5, 2
ScSco1p(1^177)/HsSco1p (chr. 22)(164^266) 5, 13a 12, 2b 5, 2
ScSco1p(1^185)/HsSco1p (chr. 22)(172^266) 5, 15a 14, 2b 5, 2
ScSco1p(1^222)/HsSco1p (chr. 22)(209^266) 5, 17a 16, 2b 5, 2
ScSco1p(1^158)/HsSco1p (chr. 22)(144^208)/ScSco1p(223^295) 5, 18c 19, 20a 5, 20
ScSco1p(1^95)/HsSco1p (chr. 17)(117^301) 5, 22a 21, 4d 5, 4
ScSco1p(1^158)/HsSco1p (chr. 17)(180^301) 5, 24a 23, 4d 5, 4
Note: the plasmids used as template encode: aScSco1p, bHsSco1p (chr. 22), cScSco1p(1^158)/HsSco1p (chr. 22)(144^266) dHsSco1p (chr. 17).
Fig. 3. Complementation behaviour of Sco1p derivates in strain GR20. vSco1 strain GR20 was transformed with YEp 351 (control (1)) or
plasmids encoding: (2) Sco1p, (3) ScSco1p(1^158)/HsSco1p (chr. 22)(144^266), (4) ScSco1p(1^158)/HsSco1p (chr. 17)(180^301), (5) HsSco1p
(chr. 22), (6) HsSco1p (chr. 17). Growth on minimal medium (WO) and glycerol medium (YPGly) was monitored after 3 days incubation at
30‡C.
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Fig. 4. Fluorescence microscopic examination of HeLa cells transfected with EGFP-bearing plasmids. HeLa cells were transfected with the indi-
cated EGFP constructs. After 24 h, cells were counterstained with the mitochondria-speci¢c dye Mito Tracker Red CMXros. A: Red £uores-
cence by Mito Tracker Red CMXros. B: Green £uorescence by EGFP. HeLa cells were transfected with plasmids encoding EGFP (I), HsSco1p
(chr. 17)-EGFP (II) and HsSco1p (chr. 22)-EGFP (III).
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We next tested whether parts of the C-terminal region of
the human chromosome 22 homolog may replace the respec-
tive yeast sequences. To this end, we progressively shortened
the C-terminal portion derived from the human homolog as
outlined in Fig. 2: ScSco1p(1^177)/HsSco1p (chr. 22)(164^
266), ScSco1p(1^185)/HsSco1p (chr. 22)(172^266) and
ScSco1p(1^222)/HsSco1p (chr. 22)(209^266). All constructs
were transformed into strain GR20 and tested for their ability
to restore the respiratory competence. None of the chimeras
was able to substitute for the ScSco1p function.
In yeast, a truncated version of ScSco1p (ScSco1p(1^258)),
lacking the C-terminal 35 amino acids, is not functional (see
Fig. 2). Because this region is one of the most divergent be-
tween the homologs, we wondered whether the authentic
ScSco1p C-terminus might be necessary for the function of
a chimeric protein. To this end we constructed the chimera
ScSco1p(1^158)/HsSco1p (chr. 22)(144^208)/ScSco1(223^295).
In this protein, the amino-terminal 158 amino acids as well as
the carboxy-terminal 73 amino acids are derived from
ScSco1p, while the internal segment corresponds to amino
acids 144^208 of HsSco1p (chr. 22). This construct too proved
not to be functional in yeast.
Although we cannot exclude the possibility that improper
folding of the chimeras interferes with their function in yeast,
we favor the idea that despite of the lesser degree of homology
(23% HsSco1p (chr. 17) versus 30% HsSco1p (chr. 22)), the
chromosome 17 homolog represents a functional ScSco1p ho-
molog. HsSco1p (chr. 22) may serve a distinct as yet unknown
function, which still has to be de¢ned.
The ¢nding that both human Sco1p proteins by themselves
fail to substitute the ScSco1p function in yeast raised the
question whether the human homologs are located in mito-
chondria. To examine the subcellular distribution, the pro-
teins were fused to EGFP and placed behind the CMV pro-
moter (see Section 2). HeLa cells were transfected with an
EGFP-bearing plasmid (control), with the HsSCO1 (chr.
22)-EGFP-bearing plasmid and with the HsSCO1 (chr. 17)-
EGFP-bearing plasmid, respectively. Transformants express-
ing the HsSco1p (chr. 17)-EGFP clearly exhibited staining in
punctuated structures (see Fig. 4). Evidence that these struc-
tures represent mitochondria was obtained by staining with
the mitochondria-speci¢c dye Mito Tracker Red CMXRos,
which resulted in an identical staining pattern. In the case
of HsSco1p (chr. 22)-EGFP, we also observed an identical
staining pattern (see Fig. 4). In contrast to HsSco1p (chr.
17)-EGFP, however, occasionally a slight green £uorescence
was also detected in the cytosol, possibly re£ecting a higher
concentration of the EGFP fusion protein or a less e⁄cient
import. HeLa cells transfected with the EGFP-bearing control
plasmid showed, as expected, an homogeneous green £uores-
cence which did not correspond to the labelling pattern with
Mito Tracker Red CMXRos (see Fig. 4). Our data demon-
strate that both chimeric HsSco1p-EGFP proteins are local-
ized in mitochondria and that mitochondrial localization is
mediated by the HsSco1p portions of the fusion proteins.
We conclude that both of the human homologs to ScSco1p
are mitochondrial proteins.
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